• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    BALAXI PHARMACEUTICALS LIMITED — Board Meeting, 28-01-2026: Outcome of Board Meeting

    28-01-2026 | 02:47 pm

    Balaxi Pharma's board approved Q3 & 9M consolidated results. Q3 net profit stood at ₹0.31 Cr, with 9M net profit at ₹0.80 Cr. The Jadcherla pharma plant is now ready for CDSCO inspection, nearing commercial operations. A Company Secretary also resigned.

    No comments yet. Be the first to comment!

    All announcements from BALAXI PHARMACEUTICALS LIMITED